Stocktoria

BioScience Health Innovations, Inc. BHIC

BioScience Health Innovations, Inc. statistics & valuation

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2022FY2021FY2020
Gross margin57.0%70.9%81.1%86.0%
Operating margin12.6%4.7%-42.1%-245.8%
Net margin11.3%4.7%-42.1%-245.8%
Return on assets37.6%10.0%-269.3%-539.3%-512.0%-405.6%-37.2%
Return on equity43.5%10.4%3720.4%992.0%-578.1%200.2%-59.9%

Source: SEC EDGAR filings · CIK 0001784440 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.